摘要
SUMU化修饰是可逆的翻译后修饰,能够结合小肽SUMO(小泛素样修饰)到靶向蛋白上。所有蛋白质在SUMO化修饰上的通路上的SUMO化修饰和SUMO化化合物的表达近期发现于组织衰退过程。此外,控制细胞衰老的关键因素是SUMO化修饰。本文对目前细胞衰老的SUMU化修饰的功能信息进行综述。
关键词: SUMO化修饰,P53,RB,衰老,老化
Current Molecular Medicine
Title:Sumoylation in Cellular Senescence and Aging
Volume: 16 Issue: 10
关键词: SUMO化修饰,P53,RB,衰老,老化
摘要: Sumoylation is a reversible post-translational modification that conjugates small peptide SUMO (small ubiquitin-like modifier) to a target protein. Global protein sumoylation and expression of components in sumoylation pathway were recently found to be altered in the process of organismal aging. In addition, key factors controlling cellular senescence are known to be sumoylated. This review will summarize current information on the function of sumoylation in cellular senescence and aging.
Export Options
About this article
Cite this article as:
Sumoylation in Cellular Senescence and Aging, Current Molecular Medicine 2016; 16 (10) . https://dx.doi.org/10.2174/1566524016666161223104915
DOI https://dx.doi.org/10.2174/1566524016666161223104915 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Virus, Oncolytic Virus and Human Prostate Cancer
Current Cancer Drug Targets Recent Advances in the Development of Selective Mcl-1 Inhibitors for the Treatment of Cancer (2017-Present)
Recent Patents on Anti-Cancer Drug Discovery Targeted Therapies in Solid Tumours: Pinpointing the Tumours Achilles Heel
Current Pharmaceutical Design Reversing Aberrant Methylation Patterns in Cancer
Current Medicinal Chemistry Metaboloepigenetics: The Emerging Network in Stem Cell Homeostasis Regulation
Current Stem Cell Research & Therapy Cancer Stem Cells in Hematological Disorders: Current and Possible New Therapeutic Approaches
Current Pharmaceutical Biotechnology The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations
Current Cancer Drug Targets DNA Methylation as a Target of Epigenetic Therapeutics in Cancer
Anti-Cancer Agents in Medicinal Chemistry An Overview of Notch Signaling in Adult Tissue Renewal and Maintenance
Current Alzheimer Research MicroRNAs in the Intracellular Space, Regulation of Organelle Specific Pathways in Health and Disease
MicroRNA Antibody-Based Preventive and Therapeutic Strategies Against HIV
Current HIV Research Radionuclide Antibody-Conjugates, a Targeted Therapy Towards Cancer
Current Radiopharmaceuticals Bid Stands at the Crossroad of Stress-Response Pathways
Current Cancer Drug Targets Stem Cell Guardians – Old and New Perspectives in LSC Biology
Current Drug Targets Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets Doxorubicin: The Good, the Bad and the Ugly Effect
Current Medicinal Chemistry Interaction of Biologically Active Amines with Mitochondria and Their Role in the Mitochondrial-Mediated Pathway of Apoptosis
Current Medicinal Chemistry Nanotechnology for Delivery of Drugs and Biomedical Applications
Current Clinical Pharmacology Pharmacogenetics and Inflammatory Bowel Disease
Current Pharmacogenomics and Personalized Medicine Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug Targets